Article thumbnail

Amelioration of Glucolipotoxicity-Induced Endoplasmic Reticulum Stress by a “Chemical Chaperone” in Human THP-1 Monocytes

By Raji Lenin, Mariawilliam Sneha Maria, Madhur Agrawal, Jayashree Balasubramanyam, Viswanathan Mohan and Muthuswamy Balasubramanyam

Abstract

Chronic ER stress is emerging as a trigger that imbalances a number of systemic and arterial-wall factors and promote atherosclerosis. Macrophage apoptosis within advanced atherosclerotic lesions is also known to increase the risk of atherothrombotic disease. We hypothesize that glucolipotoxicity might mediate monocyte activation and apoptosis through ER stress. Therefore, the aims of this study are (a) to investigate whether glucolipotoxicity could impose ER stress and apoptosis in THP-1 human monocytes and (b) to investigate whether 4-Phenyl butyric acid (PBA), a chemical chaperone could resist the glucolipotoxicity-induced ER stress and apoptosis. Cells subjected to either glucolipotoxicity or tunicamycin exhibited increased ROS generation, gene and protein (PERK, GRP-78, IRE1α, and CHOP) expression of ER stress markers. In addition, these cells showed increased TRPC-6 channel expression and apoptosis as revealed by DNA damage and increased caspase-3 activity. While glucolipotoxicity/tunicamycin increased oxidative stress, ER stress, mRNA expression of TRPC-6, and programmed the THP-1 monocytes towards apoptosis, all these molecular perturbations were resisted by PBA. Since ER stress is one of the underlying causes of monocyte dysfunction in diabetes and atherosclerosis, our study emphasize that chemical chaperones such as PBA could alleviate ER stress and have potential to become novel therapeutics

Topics: Research Article
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:3328920
Provided by: PubMed Central

Suggested articles

Citations

  1. (2007). 4-Phenylbutyrate restores the functionality of a misfolded mutant low-density lipoprotein receptor,”
  2. (2004). a ,V .A n g e l i ,J .L i u ,E .T r o g a n ,E .A .F i s h e r ,a n dG
  3. (2009). A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human α-synuclein
  4. (2008). a n ge ta l . ,“ Ac h e m i c a lc h a p e r o n e 4-PBA ameliorates palmitate-induced inhibition of glucosestimulated insulin secretion (GSIS),”
  5. (2007). Akerfeldtetal.,“Endoplasmic reticulum stress contributes to beta cell apoptosis
  6. (2009). andG.Leibowitz,“Glucoseamplifiesfattyacid-inducedendoplasmic reticulum stress in pancreatic β-cells via activation of mTORC1,”
  7. (2004). Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in
  8. (2011). Attenuation of diabetic nephropathy in diabetes rats induced by streptozotocin by regulating the endoplasmic reticulum stress inflammatory response,”
  9. (2011). Calcium entry via TRPC6 mediates albumin overload-induced endoplasmic reticulum stress and apoptosis in podocytes,”
  10. (2010). CD14+ monocytes are vulnerable and functionally impaired under endoplasmic reticulum stress in patients with type 2 diabetes,”Diabetes,
  11. (2006). Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse modeloftype2diabetes,”Science,vol.313,no.5790,pp.1137– 1140,
  12. (2003). Curcumininduced inhibition of cellular reactive oxygen species generation: novel therapeutic implications,”
  13. (2006). Depletion of intracellular Ca2+ store itself may be a major factor in thapsigargin-induced ER stress and apoptosis
  14. (2009). Diabetes modulates capacitative calcium entry and expression of transient receptor potential canonical channels in human saphenous vein,”
  15. (2006). Differential gene expression of NADPH oxidase (p22phox) and
  16. (2010). Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation,”
  17. (2007). Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword?” Antioxidants and Redox Signaling,
  18. (2010). Endoplasmic reticulum stress in diabetes: new insights of clinical relevance,”
  19. (2011). Endoplasmic reticulum stress induces retinal endothelial permeability of extracellular-superoxide dismutase,”
  20. (2001). Evidence for mechanistic alterations of
  21. (2010). Evidence for unfolded protein response activation in monocytes from individuals with α-1 antitrypsin deficiency,”
  22. (2010). High glucose-induced oxidative stress increases transient receptor potential channel expression in human monocytes,”
  23. (2011). Impaired miR-146a expression links subclinical inflammation and insulin resistance
  24. (2000). Increased intracellular generation of reactive oxygen species in mononuclear leukocytes from patients with diabetes mellitus
  25. (1988). Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes,”
  26. (2005). Increased vascular smooth muscle contractility
  27. (2002). Innate and acquired immunity in atherogenesis,”
  28. (2005). Involvement of endoplasmic reticulum stress in insulin resistance and diabetes,”
  29. (2009). ıa-Osta, “Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an alzheimer’s disease mouse model,”
  30. (2009). Life and death partners: apoptosis, autophagy and the crosstalk between them,”
  31. (2009). Molecular convergence of hexosamine biosynthetic pathway andERstressleadingtoinsulinresistanceinL6skeletalmuscle cells,”
  32. (2008). o i t o u ta n dR .P .R o b e r t s o n ,“ G l u c o l i p o t o x i c i t y :f u e le x c e s s and β-cell dysfunction,”
  33. (2011). Overexpression of Insig-1 protects β cell against glucolipotoxicity via SREBP-1c,”
  34. (2007). Oxidative DNA damage and augmentation of poly(ADP-ribose) polymerase/nuclear factor-kappa B signaling in patients with Type 2 diabetes and microangiopathy,”
  35. (2006). Oxidative stress
  36. (2007). Phenylbutyrate, a histone deacetylase inhibitor, protects against
  37. (2009). Reduced apoptosis and plaque necrosis in advanced atherosclerotic
  38. (2009). Reducing endoplasmic reticulum stress through a macrophage lipid10 Experimental Diabetes Research chaperone alleviates atherosclerosis,”
  39. (2011). Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma,”
  40. (2003). Regulation of cell death: the calcium-apoptosis link,”
  41. (2007). Signal integration in the endoplasmic reticulum unfolded protein response,”
  42. (2011). Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and β-cell dysfunction
  43. (2009). The chemical chaperon 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response,”
  44. (2007). The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients,”
  45. (2003). The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages,”
  46. (2011). The human glucagon-likepeptide-1analogueliraglutidepreservespancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes,”
  47. (2008). The role for endoplasmic reticulum stress in diabetes mellitus,”
  48. (2010). The role of endoplasmic reticulum stress in the progression of atherosclerosis,”
  49. (2006). The role of TRP channels in oxidative stressinduced cell death,”
  50. (2003). Therapeutic approaches to protein-misfolding diseases,”
  51. (2011). TRP channels and their implications in metabolic diseases,”
  52. (2009). TRPC channels and store-operated
  53. (2006). TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy,”
  54. (2007). Ubiquitinated-protein aggregates form in pancreaticβ-cellsduringdiabetes-inducedoxidativestressand are regulated by autophagy,” Diabetes,
  55. (1996). Urea cycle disorders: diagnosis, pathophysiology, and therapy,”

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.